Introduction of misoprostol into the Nigerian market: Challenges by Otisi, L
78
Trop J Obstet Gynaecol, Vol 27 (1), April 2010
Complications of Postpartum Hemorrhage 
vOrthostatic hypotension;
Anemia and fatigue, which may make 
maternal care of the newborn more difficult;
vPostpartum anaemia which increases the 
risk of postpartum depression;
vBlood transfusion with its associated risks 
may be necessary;
vIn the most severe cases, haemorrhagic 
shock may lead to anterior pituitary 
ischemia with delay or failure of lactation 
(i.e. postpartum pituitary necrosis); and
vMaternal death 
PREVENTION OF PPH
Active Management of the Third Stage of labour 
(AMTSL): This includes administration of 
uterotonics (oxytocics) within 1 minute of birth , 
early cord clamping & cutting and controlled 
traction to deliver the placenta (with counter-
traction on the uterus).
Prevention of PPH Using Uterotonic Drugs
§ Administration of oxytocin immediately 
after childbirth is probably the single most 
important intervention to prevent PPH.
§  A woman receiving a uterotonic delivers 
placenta faster & less likely to require manual 
removal of placenta.
Challenges Associated With the Use of 
Traditional Oxytocic Drugs (Oxytocin and 
Ergometrine)
vCost – training of health workers for safe 
administration/accessories;
vStorage – oxytocin and ergot derivatives are 
thermolabile & must be refrigerated to remain 
effective; 
vSafe handling – parenteral administration 
requires skilled personnel ;
vS a f e t y  –  E rg o t  d e r i v a t i v e s  a r e  
contraindicated in hypertensive women and can 
cause severe headache, convulsion & even 
death;
vRisk of water intoxication from rapid 
infusion with oxytocin due to its antidiuretic 
vNigeria has one of the highest maternal 
mortality ratios in the world.
vThe national average for MMR is 
1000/100,000 live births (with wide regional 
disparities)
vThe major causes of deaths are post partum 
haemorrhage (PPH) (20-30%), eclampsia 
(23%), sepsis (17%) and unsafe abortion (25-
40%). 
vUterine atony accounts for over 70% of 
deaths from PPH.
vAll of these causes of maternal deaths are 
preventable.
POST PARTUM HAEMORRHAGE (PPH)
Definition
vBlood loss after birth in excess of 500ml or 
of such magnitude as to alter the haemodynamic 
state of the mother irrespective of the quantity of 
blood loss.
Types of PPH
vPrimary–within the first 24hrs of delivery.
Secondary- after the first 24hrs and within 
the first 6 wks of delivery.
Risk Factors for PPH
vUterine atony. 
Little or no access to proper & emergency 
medical services.
vLack of skilled health providers.
Delay due to inefficient transport system.
vHigh incidence of pre-existing anaemia.
Significant risk factors for PPH were: 
prolonged second and third stages of labour, 
non-use of oxytocics after delivery, grand 
multiparity, previous PPH and primigravidity 
(1).
Contribution of Various Obstetric Causes of 
PPH in Nigeria 
§Uterine atony (85% - 90%) – Failure of the 
uterus to contract after delivery;
§Genital tract trauma( 10%) – vaginal, 
cervical and perineal lacerations, etc; and
§Clotting defects (2%).
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hypertension.
vIn pre-eclamptic patients, it may cause 
 
headaches,convulsion and even death. 
vMisoprostol does not cause hypertension 
 
andis associated with a 55–60% reduction in the 
 
incidence of hypertension when compared with 
syntometrine. Misoprostol is also a potent 
vasodilator. Its vasodilatory effects appears to 
involve arterioles, pre-capillary sphincters and 
post capillary venules, leading to a decrease in 
the total peripheral resistance and a consequent 
fall in blood pressure. It reduces the mean 
arterial pressure and systemic vascular 
resistance and has a modest and transient 
antihypertensive effect in patients with essential 
hypertension. Thus Misoprostol is a suitable 
oxytocic agent in hypertensive and pre-
eclamptic women undergoing vaginal delivery 
while ergometrine is contraindicated in women 
with pregnancy-induced hypertension (7). 
Dosage
vFor prevention of PPH: 600 µg (3 tablets) to 
be taken orally.
vFor treatment of PPH: 1000 µg (5 tablets) to 
be taken orally/administered rectally.
Side Effects
v Misoprostol-related pyrexia (usually 38-




A toxic dose has not been established. Cumulative 
doses of up to 2,200 µg every 12 hours have been 
administered without serious side effects. Unlike 
PGE  and PGF , Misoprostol does not cause 2 2a





§ Is stable at ambient temperature -  No need 
for special storage;
§ Effective  –  stops PPH in minutes;
§ Has  versatile routes of administration - can 
be administered orally, bucally, sublingually 
and rectally;
§Main oxytocic agent in hypertensive and 
pre-eclamptic women - most suitable and safe 
for women with high BP in pregnancy;
§ Approved and vailable in Nigeria – Listed in 
the WHO essential drug list.
properties;
vAssociation of intrapartum oxytocin with 
neonatal jaundice; and
vPresence of many fake & substandard 
brands in the market because of their popularity.
 
THE WAY FORWARD? 
Misoprostol: The Life-Saving Prostaglandin 
Analogue 
vMisoprostol is an E  prostaglandin 1
analogue:
o It binds selectively to EP2/EP3 receptors of 
the myometrium - uterotonic property;
o It has a fast onset of action – peak plasma 
levels of misoprostol acid achieved within 
12 (± 3) minutes;
o It is thermostable and remains effective even 
in tropical climate; 
o It is relatively affordable; and 




§ Buccal /sublingual - rapid onset. 
vPharmacokinetics: 
o Bioavailability: it is extensively absorbed.  
o Metabolism: de-esterified to misoprostol 
acid, then to prostaglandin-F analogues.
o Half life: 20–40 minutes.
o Excretion: renal (80%) and faecal (15%).
o Mean plasma concentrations of misoprostol 
acid is reached within a short time with oral, 
rectal, and vaginal administration (2).
  o Rectal misoprostol may have a higher
bioavailability in the third stage of labour , 
 
because  the rectal mucosa is moister and thus 
enhances absorption. When misoprostol 600 µg 
 
is administered in the third stage of labour, peak 
levels higher than those noted above are 
achieved by both the oral and rectal route (3). 
vBenefits of Using Misoprostol 
o Incidence of manual removal of placenta is 
less than with other oxytocic agents due to their 
different uterotonic effects. Ergometrine 
induces tonic uterine contractions while 
misoprostol induces rhythmic uterine 
contractions (4). 
Ergometrine versus Misoprostol (5, 6)
vThe use of syntometrine is contraindicated 
 in hypertensive patients as ergometrine 
stimulates vasoconstriction and causes 
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